Drug Approval | August 18, 2023
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Subscribe To Our Newsletter & Stay Updated
